Table 6.
Risk factors
| Variable | β | SE | P | OR value | Lower | Upper |
|---|---|---|---|---|---|---|
| FIGO staging | 0.417 | 0.169 | 0.014 | 1.517 | 1.081 | 2.108 |
| Tumor size | 0.054 | 0.296 | 0.857 | 1.055 | 0.589 | 1.894 |
| Differentiation degree | 0.241 | 0.159 | 0.131 | 1.272 | 0.931 | 1.742 |
| Lymphovascular invasion | -0.369 | 0.376 | 0.326 | 0.691 | 0.334 | 1.469 |
| SCC-Ag (ng/mL) | 3.180 | 0.402 | <0.001 | 24.057 | 11.246 | 54.739 |
| WBC (×109/L) | -0.877 | 0.360 | 0.015 | 0.416 | 0.200 | 0.827 |
| NEUT (×109/L) | -1.268 | 0.352 | <0.001 | 0.281 | 0.140 | 0.560 |
| HGB (g/L) | -0.969 | 0.343 | 0.005 | 0.379 | 0.192 | 0.741 |
| AST (U/L) | 0.437 | 0.338 | 0.196 | 1.548 | 0.792 | 3.003 |
| PAB (mg/L) | -0.777 | 0.329 | 0.018 | 0.460 | 0.239 | 0.874 |
| LDL (mmol/L) | -0.772 | 0.437 | 0.077 | 0.462 | 0.186 | 1.044 |
Note: FIGO, International Federation of Obstetrics and Gynecology; SCC-Ag, squamous cell carcinoma antigen; WBC, white blood cell count; NEUT, neutrophil count; HGB, hemoglobin; AST, aspartate aminotransferase; PAB, prealbumin; LDL, low-density lipoprotein.